US · PNTG · MEDICAL - CARE FACILITIES
The Pennant Group, Inc. (PNTG) intrinsic value and stock valuation
$34.64as of 2026-11-21 · Mkt cap 1.35B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
The Pennant Group, Inc. DCF and intrinsic value
InvestorsCraft values PNTG with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from PNTG’s statements →
The Pennant Group, Inc. Graham Number
Graham Number: $14.44d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2016–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Sonida Senior Living, Inc. (SNDA) $31.47
- Innovage Holding Corp. (INNV) $9.16
- Bicara Therapeutics Inc. Common Stock (BCAX) $8.44
- Integra LifeSciences Holdings Corporation (IART) $13.25
- AMN Healthcare Services, Inc. (AMN) $35.68
- EyePoint Pharmaceuticals, Inc. (EYPT) $0.23
- HealthStream, Inc. (HSTM) $26.29
- Kura Oncology, Inc. (KURA) $6.91
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $947.7M | $695.2M | $544.9M | $473.2M | $439.7M |
| Operating income | $51.4M | $38.1M | $25.2M | $12.7M | $4.7M |
| Net income | $29.6M | $22.6M | $13.4M | $6.64M | $2.7M |
| EPSd | $837.5K | $705K | $443.2K | $220.2K | $88.1K |
| Operating cash flow | $48.3M | $39.3M | $33.1M | $9.04M | -$-18.22M |
| Capital expenditure | -$-22M | -$-8.99M | -$-8.11M | -$-14.17M | -$-6.3M |
| Free cash flow | $26.3M | $30.3M | $25M | -$-5.13M | -$-24.53M |
| Total assets | $968.2M | $679.5M | $539.7M | $512.1M | $530.3M |
| Total debt | $453.2M | $273.1M | $329.6M | $326.6M | $355.2M |
| Net debt | $436.1M | $248.8M | $323.6M | $324.5M | $350.1M |
| Total equity | $374.3M | $312M | $145.5M | $125.7M | $114.2M |
| Cash and short-term investments | $17M | $24.3M | $6.06M | $2.08M | $5.19M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $947.7M | $695.2M | $544.9M | $473.2M | $439.7M |
| Cost of revenue | $825.2M | $601.5M | $477.9M | $414.7M | $391.1M |
| Gross profit | $122.5M | $93.8M | $67M | $58.6M | $48.6M |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $71.1M | $50.2M | $36.7M | $34M | $36.3M |
| Other expenses | $0.00 | $5.44M | $5.2M | $11.9M | $7.64M |
| Operating expenses | $71.1M | $55.7M | $41.9M | $45.9M | $43.9M |
| Cost and expenses | $896.3M | $657.1M | $519.7M | $460.5M | $435M |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $6.68M | $6.96M | $5.92M | $3.82M | $1.94M |
| Depreciation and amortization | $8.54M | $6.12M | $5.13M | $4.9M | $4.78M |
| Ebitda | $60.9M | $44.4M | $30.6M | $17.6M | $9.46M |
| Operating income | $51.4M | $38.1M | $25.2M | $12.7M | $4.7M |
| Total other income/expenses, net | -$-5.76M | -$-6.75M | -$-5.58M | -$-3.85M | -$-1.97M |
| Income before tax | $45.6M | $31.4M | $19.6M | $8.89M | $2.73M |
| Income tax expense | $11.9M | $7.03M | $5.67M | $1.65M | $580K |
| Net income | $29.6M | $22.6M | $13.4M | $6.64M | $2.7M |
| Weighted average shares outstanding | $34.6M | $31.2M | $29.9M | $29.1M | $28.4M |
| Weighted average diluted shares outstanding | $35.3M | $32M | $30.2M | $30.2M | $30.6M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $17M | $24.3M | $6.06M | $2.08M | $5.19M |
| Net receivables | $123.1M | $81.3M | $61.1M | $53.4M | $53.9M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current assets | $167.4M | $122.9M | $80.1M | $73.8M | $75.8M |
| Property, plant and equipment, net | $336.9M | $313.9M | $291.5M | $287.5M | $317.8M |
| Goodwill and intangible assets | $436.7M | $225.3M | $158.8M | $138.1M | $128M |
| Long-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current assets | $800.8M | $556.7M | $459.6M | $438.3M | $454.5M |
| Total assets | $968.2M | $679.5M | $539.7M | $512.1M | $530.3M |
| Accounts payable | $25.2M | $18.7M | $10.8M | $13.7M | $10.6M |
| Short-term debt | $30M | $19.7M | $17.1M | $16.6M | $16.1M |
| Deferred revenue | $2.29M | $2.28M | $1.66M | $1.59M | $7.67M |
| Total current liabilities | $147.3M | $101.7M | $71.6M | $70.3M | $71.6M |
| Long-term debt | $423.2M | $253.4M | $312.5M | $309.9M | $339.1M |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | -$-88.21M |
| Total non-current liabilities | $446.7M | $265.9M | $322.6M | $316.2M | $344.4M |
| Capital lease obligations | $279.3M | $273.1M | $265.7M | $263.7M | $303.9M |
| Total liabilities | $593.9M | $367.6M | $394.2M | $386.5M | $416.1M |
| Common stock | $40K | $40K | $30K | $30K | $30K |
| Retained earnings | $86.8M | $57.2M | $34.7M | $21.3M | $14.6M |
| Accumulated other comprehensive income (loss) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total equity | $374.3M | $312M | $145.5M | $125.7M | $114.2M |
| Total investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $453.2M | $273.1M | $329.6M | $326.6M | $355.2M |
| Net debt | $436.1M | $248.8M | $323.6M | $324.5M | $350.1M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $33.8M | $24.3M | $13.9M | $7.24M | $2.15M |
| Depreciation and amortization | $8.54M | $6.12M | $5.13M | $4.9M | $4.78M |
| Stock-based compensation | $8.94M | $7.78M | $5.37M | $3.09M | $10M |
| Change in working capital | -$-1.59M | $930K | $3.44M | -$-9.5M | -$-37.38M |
| Accounts receivable | -$-24.15M | -$-21.09M | -$-7.35M | -$-360K | -$-7.33M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | $5.8M | $8.05M | -$-1.84M | $2.37M | $560K |
| Net cash provided by operating activities | $48.3M | $39.3M | $33.1M | $9.04M | -$-18.22M |
| Investments in property, plant and equipment | -$-22M | -$-8.99M | -$-8.11M | -$-14.17M | -$-6.3M |
| Acquisitions, net | -$-204.02M | -$-48.42M | -$-21.38M | -$-10.13M | -$-13.55M |
| Net cash used for investing activities | -$-227.97M | -$-70.68M | -$-30.22M | -$-24.24M | -$-20.12M |
| Common stock issued | $550K | $119M | $580K | $1.08M | $0.00 |
| Common stock repurchased | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | $172.5M | $49.6M | $1.11M | $12.1M | $43.5M |
| Net change in cash | -$-7.22M | $18.2M | $3.98M | -$-3.11M | $5.15M |
| Cash at end of period | $17M | $24.3M | $6.06M | $2.08M | $5.19M |
| Operating cash flow | $48.3M | $39.3M | $33.1M | $9.04M | -$-18.22M |
| Capital expenditure | -$-22M | -$-8.99M | -$-8.11M | -$-14.17M | -$-6.3M |
| Free cash flow | $26.3M | $30.3M | $25M | -$-5.13M | -$-24.53M |
Line items
Line items
Line items
About The Pennant Group, Inc.
The Pennant Group, Inc. is a U.S.-based healthcare provider, delivering a diverse range of services through two core divisions: Home Health and Hospice Services, and Senior Living Services. The company's Home Health segment offers in-home clinical support, encompassing nursing, speech, occupational, and physical therapy, as well as medical social work and home health aide assistance. Its Hospice services focus on providing comprehensive clinical care, education, and counseling to meet the physical, spiritual, and psychosocial needs of terminally ill patients and their families. In its Senior Living division, Pennant provides residential accommodations, organized activities, meals, housekeeping, and aid with daily living tasks for seniors who are either independent or require some support. As of December 31, 2021, the company's extensive operational footprint included 88 home health and hospice agencies and 54 senior living communities, collectively featuring 4,127 senior living units. These facilities are located across Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was established in 2019 and maintains its corporate headquarters in Eagle, Idaho.
- CEO
- Brent J. Guerisoli
- Employees
- 9.7K
- Beta
- 1.25
Included in
Explore
Frequently asked questions
What is the intrinsic value of The Pennant Group, Inc. (PNTG)?
The Pennant Group, Inc. (PNTG) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is PNTG undervalued?
PNTG trades at a price of $34.64 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.